Key Metrics
5.4
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.9
5-Year SI
5-year SI
- 0.89 2-year SI
- 0.88 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q3
Hematology
SJR
- Q3 Hematology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.9
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
5 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
8%
4 to 6 months
58%
7 to 9 months
25%
Above 9 months
9%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Precision medicine
- Bone marrow
- Coagulopathy
- Immune thrombocytopenia
- Chimeric antigen receptor
- Minimal residual disease
- Dexamethasone
- Cancer predisposition
- Anemia
- Von willebrand
- Mantle cell lymphoma
- Myelofibrosis
- Fusion gene
- Therapy-Related Acute Myeloid Leukemia
- Ex vivo
- Ibrutinib
- Hematopoietic stem cell transplantation
- Drug resistance
- Overall survival
- Essential thrombocythemia
Journal Specifications
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | USD 1200 |
| Publication Time | 7 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | European Hematology Association |
| Frequency | Monthly |
| Publication Start Year | 2017 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Other charges | Visit website |
| Publication Time | 7 |
| Article Processing Charges | USD 1200 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Double anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC, CC BY-SA, CC BY-NC-ND, CC BY-ND, CC BY-NC-SA |
| OA statement | Visit website |
Planning to publish in HemaSphere ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Definitions matter: Multicenter investigation of incidence and outcome of poor graft function after hematopoietic cell transplantation.
- 1 Dec 24
- HemaSphere
-
Full paper
Novel approaches in myelofibrosis.
- 1 Dec 24
- HemaSphere
-
Full paper
Issue Information
- 1 Dec 24
- HemaSphere
-
Full paper
Issue Information
- 1 Dec 24
- HemaSphere
-
Full paper
Title not available
- 1 Dec 24
- HemaSphere
-
Full paper
Time-restricted versus standard-duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON-96 trial.
- 1 Dec 24
- HemaSphere
Scite analysis
Powered by scite_
8.9k articles received 8.6k citations see all
- 340 Supporting
- 8,047 Mentioning
- 43 Contrasting
Editorial notices
- 0 Retractions
- 1 Withdrawals
- 0 Corrections
- 11 Errata
- 0 Expression of Concern
FAQs
How long has HemaSphere been actively publishing?
HemaSphere has been in operation since 2017 till date.
What is the publishing frequency of HemaSphere ?
HemaSphere published with a Monthly frequency.
How many articles did HemaSphere publish last years ?
In 2024, HemaSphere published 194 articles.
What is the eISSN & pISSN for HemaSphere ?
For HemaSphere,eISSN is 2572-9241 and pISSN is2572-9241.
What is Citescore for HemaSphere ?
Citescore for HemaSphere is 5.4.
What is SNIP score for HemaSphere ?
SNIP score for HemaSphere is 0.9.
What is the SJR for HemaSphere ?
SJR for HemaSphere is Q3.
Who is the publisher of HemaSphere ?
LIPPINCOTT WILLIAMS & WILKINS is the publisher of HemaSphere.